Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians
WA Hall, E Paulson, XA Li, B Erickson… - CA: a cancer journal …, 2022 - Wiley Online Library
Radiation therapy (RT) continues to play an important role in the treatment of cancer.
Adaptive RT (ART) is a novel method through which RT treatments are evolving. With the …
Adaptive RT (ART) is a novel method through which RT treatments are evolving. With the …
Multiparametric MRI and radiomics in prostate cancer: a review
Y Sun, HM Reynolds, B Parameswaran… - Australasian physical & …, 2019 - Springer
Multiparametric MRI (mpMRI) is an imaging modality that combines anatomical MR imaging
with one or more functional MRI sequences. It has become a versatile tool for detecting and …
with one or more functional MRI sequences. It has become a versatile tool for detecting and …
Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study
V Panebianco, F Barchetti, A Sciarra, A Ciardi… - … oncology: seminars and …, 2015 - Elsevier
Objectives To assess whether the proportion of men with clinically significant prostate
cancer (PCa) is higher among men randomized to multiparametric magnetic resonance …
cancer (PCa) is higher among men randomized to multiparametric magnetic resonance …
Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection …
JE Thompson, D Moses, R Shnier, P Brenner… - The Journal of …, 2014 - auajournals.org
Purpose: Multiparametric magnetic resonance imaging appears to improve prostate cancer
detection but prospective studies are lacking. We determined the accuracy of …
detection but prospective studies are lacking. We determined the accuracy of …
Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer
J Wang, J Ni, J Beretov, J Thompson, P Graham… - Critical reviews in …, 2020 - Elsevier
Prostate cancer (PCa) is the most commonly diagnosed solid-organ cancer in males. The
PSA testing may cause overdiagnosis and overtreatment for PCa patients. There is an …
PSA testing may cause overdiagnosis and overtreatment for PCa patients. There is an …
Multiparametric MRI in prostate cancer management
Prostate cancer is the second most common cancer in men worldwide. The clinical
behaviour of prostate cancer ranges from low-grade indolent tumours that never develop …
behaviour of prostate cancer ranges from low-grade indolent tumours that never develop …
MRI-LINAC: A transformative technology in radiation oncology
Advances in radiotherapy technologies have enabled more precise target guidance,
improved treatment verification, and greater control and versatility in radiation delivery …
improved treatment verification, and greater control and versatility in radiation delivery …
A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy
Objective To develop and externally validate a predictive model for detection of significant
prostate cancer. Patients and Methods Development of the model was based on a …
prostate cancer. Patients and Methods Development of the model was based on a …
mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer-a retrospective review of 92 biopsied PIRADS 3 …
H Liddell, R Jyoti, HZ Haxhimolla - Current urology, 2015 - karger.com
Objective: To determine whether prostate image reporting and data system (PIRADS) 3
lesions as assessed by a 3T multiparametric magnetic resonance imaging (MRI) represent …
lesions as assessed by a 3T multiparametric magnetic resonance imaging (MRI) represent …
Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI
Objectives To investigate the added value of computer-aided diagnosis (CAD) on the
diagnostic accuracy of PIRADS reporting and the assessment of cancer aggressiveness …
diagnostic accuracy of PIRADS reporting and the assessment of cancer aggressiveness …